-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Processa Pharma (NASDAQ:PCSA) shares moved upwards by 32.6% to $2.7 during Wednesday's pre-market session. The company's market cap stands at $5.5 million.
  • Polyrizon (NASDAQ:PLRZ) stock increased by 28.2% to $14.68. The market value of their outstanding shares is at $23.8 million.
  • Envoy Medical (NASDAQ:COCH) shares rose 9.48% to $0.68. The market value of their outstanding shares is at $47.6 million.
  • InnovAge Holding (NASDAQ:INNV) stock rose 8.45% to $8.34. The company's market cap stands at $1.0 billion.
  • Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 6.8% to $0.4. The market value of their outstanding shares is at $18.1 million.
  • Citius Pharmaceuticals (NASDAQ:CTXR) shares moved upwards by 6.74% to $0.59. The market value of their outstanding shares is at $15.2 million.

Losers

  • Basel Medical Group (NASDAQ:BMGL) stock decreased by 32.6% to $0.43 during Wednesday's pre-market session. The company's market cap stands at $11.9 million.
  • Aditxt (NASDAQ:ADTX) shares declined by 27.69% to $0.02.
  • Regentis Biomaterials (AMEX:RGNT) shares fell 23.66% to $1.84. The market value of their outstanding shares is at $12.4 million.
  • Picard Medical (AMEX:PMI) shares fell 21.72% to $0.25. The company's market cap stands at $29.8 million.
  • Cuprina Holdings (Cayman) (NASDAQ:CUPR) stock fell 20.17% to $1.9. The company's market cap stands at $6.3 million.
  • Dianthus Therapeutics (NASDAQ:DNTH) stock decreased by 19.95% to $67.7. The market value of their outstanding shares is at $4.6 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending